secwatch / observer
8-K filed September 2, 2026, 4:50 PM ET ticker NXL CIK 0001527352
leadership confidence high sentiment neutral materiality 0.50

Nexalin SVP Quality/Regulatory/Clinical Carolyn Shelton departs; separation terms set

Nexalin Technology, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Carolyn Shelton

Senior Vice President of Quality, Regulatory, and Clinical Affairs
NXL · Nexalin Technology, Inc.
Effective
2026-08-28
Filed
September 2, 2026, 4:50 PM ET
On August 28, 2026, Carolyn Shelton departed from her role as Senior Vice President of Quality, Regulatory, and Clinical Affairs of Nexalin Technology, Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carolyn Shelton departed as Senior Vice President of Quality, Regulatory, and Clinical Affairs at Nexalin Technology, Inc..

Action
departed
Role
Senior Vice President of Quality, Regulatory, and Clinical Affairs
Exact text from the filing
On August 28, 2026, Carolyn Shelton departed from her role as Senior Vice President of Quality, Regulatory, and Clinical Affairs of Nexalin Technology, Inc. (the “Company”).
View on SEC.gov

Nexalin Technology, Inc. filing history →

Source: SEC EDGAR
accession 0001829126-26-009659
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.